There has been long-running controversy regarding the association between statins and PD risk. Two studies with conflicting results are examined here.
Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
New FNIH Initiative Looks to Expedite Parkinson Disease Diagnosis Through Validated Biomarkers
Paradigm Shift in Parkinson’s Disease Diagnosis
This Week on NeurologyLive® — July 22, 2024
NeurologyLive® Brain Games: July 21, 2024